GlassScriptPhysician profile
Michael R Hutzel
NPI 1457347361
$63,595.82
in general payments reported to CMS, 2019-2025
33 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,205 · 2020: $256 · 2021: $655 · 2022: $58K · 2023: $1,436 · 2024: $1,082 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolab Sciences, INC. | $56,450.00 | 2022 | |
| Organogenesis INC. | $1,334.22 | 2019-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Smith+Nephew, INC. | $1,137.94 | 2019-2025 | Collagenase Santyl, Regranex, Grafix |
| Medical Device Business Services, INC. | $918.48 | 2019 | |
| Abbvie INC. | $679.85 | 2022-2025 | |
| Abbott Laboratories | $319.92 | 2019-2021 | |
| Misonix INC | $280.13 | 2019-2021 | |
| Wright Medical Technology, INC. | $261.47 | 2019 | |
| Medtronic Vascular, INC. | $223.08 | 2019 | |
| Bioventus LLC | $218.45 | 2021-2023 | Theragenesis Bilayer Wound Matrix |
| Nevro Corp. | $198.99 | 2022-2023 | Senza |
| Mimedx Group, INC. | $179.79 | 2024-2025 | |
| Averitas Pharma INC. | $176.54 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $164.08 | 2022-2023 | Nuzyra |
| Treace Medical Concepts, INC. | $145.94 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $138.41 | 2024 | |
| Kci USA, INC. | $128.00 | 2019 | |
| Melinta Therapeutics, LLC | $124.59 | 2023 | Kimyrsa |
| Zimmer Biomet Holdings, INC. | $110.30 | 2019 | |
| Resmed Corp | $52.15 | 2022 | |
| Tactile Systems Technology INC | $47.01 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Acera Surgical, INC. | $39.55 | 2024 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $35.04 | 2020-2024 | |
| Kerecis Limited | $31.34 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $31.05 | 2025 | Physio-Stim |
| Kuros Biosciences USA, INC | $28.82 | 2022 | |
| Advanced Oxygen Therapy INC. | $28.40 | 2025 | Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $28.12 | 2020-2021 | |
| Lifenet Health | $22.33 | 2023 | |
| Hydrofera LLC | $16.98 | 2023 | Hydrofera Blue |
| Horizon Therapeutics Plc | $16.45 | 2021 | |
| Tei Medical INC. | $15.97 | 2019 | |
| Convatec INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hutzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.